Corcept Therapeutics Incorporated Operating Cash Flow 2011-2026 | CORT

Annual Operating Cash Flow Corcept Therapeutics Incorporated

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
142 M	198 M	127 M	120 M	168 M	152 M	136 M	116 M	60.9 M	18.4 M	-	-	-37.1 M	-36 M	-27.4 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
198 M	-37.1 M	87.5 M

Quarterly Operating Cash Flow Corcept Therapeutics Incorporated

2025-Q3	2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	5.13 M	-	-	23.8 M	-	-	26 M	-	86.9 M	-	35.2 M	-	118 M	-	25.4 M	-	117 M	86.5 M	33.3 M	-	87.7 M	49.2 M	23.7 M	-	94.1 M	49.6 M	34.4 M	-	36.1 M	25.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-11.6 M	-	-27.3 M	-18 M	-10.2 M	-	-21.1 M	-14.5 M	-7.3 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
118 M	-27.3 M	33.9 M

Operating Cash Flow of other stocks in the Biotechnology industry

Issuer	Operating Cash Flow	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	-481 M	-	2.43 %	$ 254 M	Germany
Amarin Corporation plc AMRN	6.73 M	$ 14.6	-0.54 %	$ 6.06 B	Irlanda
ARCA biopharma ABIO	-57.8 M	-	1052.0 %	$ 415 M	USA
Aeterna Zentaris AEZS	-8.58 M	-	5.93 %	$ 314 M	Canada
Akero Therapeutics AKRO	-230 M	-	-	$ 3.67 B	USA
Akouos AKUS	-63.7 M	-	0.23 %	$ 488 M	USA
I-Mab IMAB	-1.3 B	-	-	$ 866 M	China
Genfit SA GNFT	99.9 M	-	2.54 %	$ 160 B	France
Albireo Pharma ALBO	-108 M	-	-0.23 %	$ 916 M	USA
Biophytis SA BPTS	-23.8 M	-	-13.47 %	$ 169 M	France
Aileron Therapeutics ALRN	-22.3 M	-	10.36 %	$ 9.8 M	USA
Midatech Pharma plc MTP	-6.01 M	-	-18.52 %	$ 27.3 M	Britain
Cabaletta Bio CABA	-131 M	$ 2.8	0.67 %	$ 281 M	USA
Applied Genetic Technologies Corporation AGTC	-65.7 M	-	-	$ 26.5 M	USA
Editas Medicine EDIT	-165 M	$ 2.32	-	$ 206 M	USA
Enlivex Therapeutics Ltd. ENLV	-13 M	$ 1.1	-8.75 %	$ 22.6 M	Israel
AgeX Therapeutics AGE	-18 M	-	-10.17 %	$ 12.2 K	USA
Aptinyx APTX	-59.7 M	-	-39.0 %	$ 4.57 M	USA
Acorda Therapeutics ACOR	-14 M	-	-24.86 %	$ 820 K	USA
Eton Pharmaceuticals ETON	10.5 M	$ 23.69	-0.63 %	$ 637 M	USA
Esperion Therapeutics ESPR	-13.1 M	$ 2.86	3.62 %	$ 594 M	USA
Acasti Pharma ACST	-14.9 M	-	4.01 %	$ 150 M	Canada
EyePoint Pharmaceuticals EYPT	-240 M	$ 13.05	-	$ 956 K	USA
Equillium EQ	-22.7 M	$ 2.06	-	$ 118 M	USA
Adverum Biotechnologies ADVM	-92.5 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	-30.3 M	-	2.71 %	$ 14 M	USA
Advaxis ADXS	-29.5 M	-	-9.65 %	$ 45.9 M	USA
Ayala Pharmaceuticals AYLA	-34.5 M	-	-	$ 7.46 M	Israel
Avenue Therapeutics ATXI	-9.03 M	-	-52.27 %	$ 4.45 M	USA
Autolus Therapeutics plc AUTL	-206 M	$ 1.32	-1.13 %	$ 337 M	Britain
Atreca BCEL	-80.7 M	-	-11.76 %	$ 5.79 M	USA
Halozyme Therapeutics HALO	652 M	$ 63.36	0.19 %	$ 7.59 B	USA
BeiGene, Ltd. BGNE	1.13 B	-	0.49 %	$ 251 B	Cayman-islands
Savara SVRA	-101 M	$ 5.26	-0.47 %	$ 1.17 B	USA
bluebird bio BLUE	-235 M	-	-	$ 546 M	USA
Harmony Biosciences Holdings HRMY	348 M	$ 27.52	-0.25 %	$ 1.58 B	USA
Heron Therapeutics HRTX	-27.6 M	$ 0.82	3.09 %	$ 137 M	USA
BioDelivery Sciences International BDSI	41 M	-	-4.8 %	$ 255 M	USA
Cara Therapeutics CARA	-92.1 M	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	-75.6 M	-	-	$ 3.74 B	USA
Aeglea BioTherapeutics AGLE	-169 M	-	-	$ 1.01 B	USA
Avid Bioservices CDMO	11 M	-	-	$ 789 M	USA
CureVac N.V. CVAC	-733 M	-	-	$ 867 M	Germany
Iterum Therapeutics ITRM	-26.8 M	$ 0.18	2.15 %	$ 3.55 M	Irlanda
Bellerophon Therapeutics BLPH	-17.8 M	-	-74.18 %	$ 955 K	USA
Johnson & Johnson JNJ	24.5 B	$ 240.05	0.03 %	$ 578 B	USA
Kala Pharmaceuticals KALA	-29.4 M	$ 0.21	-3.22 %	$ 797 K	USA